CHAD M. ROBINS

Insider Reports History

Location
Seattle, WA
Signature
/s/ Chad M. Robins by Kyle Piskel, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by CHAD M. ROBINS:

Company Role Class Num Shares Value Price $ Report Date Ownership
Adaptive Biotechnologies Corp CEO and Chairman, Director Common Stock 2,709,241 $51,313,024 $18.94 01 Dec 2025 Direct
Adaptive Biotechnologies Corp CEO and Chairman, Director Stock Option (right to buy) 0 20 Feb 2025 Direct

Insider Reports Filed by CHAD M. ROBINS

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ADPT Adaptive Biotechnologies Corp 26 Nov 2025 2 $3,070,747 4 CEO and Chairman, Director 01 Dec 2025, 19:27
ADPT Adaptive Biotechnologies Corp 10 Nov 2025 3 $1,315,180 4 CEO and Chairman, Director 12 Nov 2025, 19:19
ADPT Adaptive Biotechnologies Corp 04 Mar 2025 5 $1,600,417 4 CEO and Chairman, Director 06 Mar 2025, 19:17
ADPT Adaptive Biotechnologies Corp 19 Feb 2025 6 $608,318 4 CEO and Chairman, Director 21 Feb 2025, 19:28
ADPT Adaptive Biotechnologies Corp 13 Feb 2025 9 $1,013,028 4 CEO and Chairman, Director 18 Feb 2025, 20:21
ADPT Adaptive Biotechnologies Corp 04 Mar 2024 3 $167,007 4 CEO and Chairman, Director 06 Mar 2024, 19:40
ADPT Adaptive Biotechnologies Corp 06 Mar 2023 1 $0 4 CEO and Chairman, Director 08 Mar 2023, 19:00
ADPT Adaptive Biotechnologies Corp 07 Mar 2022 10 $617,982 4 CEO and Chairman, Director 09 Mar 2022, 18:00
ADPT Adaptive Biotechnologies Corp 04 Mar 2022 2 $53,132 4 CEO and Chairman, Director 08 Mar 2022, 20:00
ADPT Adaptive Biotechnologies Corp 08 Sep 2021 5 $1,671,496 4 CEO and Chairman, Director 10 Sep 2021, 21:00
ADPT Adaptive Biotechnologies Corp 12 Jul 2021 1 $57,398 4 CEO and Chairman, Director 14 Jul 2021, 21:00
ADPT Adaptive Biotechnologies Corp 15 Jun 2021 5 $1,153,965 4 CEO and Chairman, Director 17 Jun 2021, 21:00